医学检验科主任/海南热带肿瘤研究所副所长（主持工作），博士、研究员、教授、博士研究生导师。海南省“515人才工程”第二层次人才、海南省高层次人才D类人才。海南省临床检验诊断学专家，海南省卫健委临床检验中心临床基因扩增实验室评审专家。
多年来，立足临床检验诊断工作的同时，在鼻咽癌、乳腺癌致病机制、地中海贫血分子诊断和防治领域、干细胞临床转化取得了多项创新研究成果。主持承担多项国家自然科学基金委和海南省科技厅科研项目，以第一作者或通讯作者发表SCI论文14篇，最高影响因子24分，其中多篇文章在Frontiers in Cell and Developmental Biology、Molecular Therapy-Oncolytic 等肿瘤医学国际主流期刊发表。
临床检验诊断学、临床分子诊断、实验室质量管理、医学遗传学、遗传咨询、法医物证鉴定（亲权鉴定）。
一、肿瘤发病机制及肿瘤靶向药物与早期筛查试剂盒研发
二、肠道微生态与肿瘤关系的机制研究
三、干细胞临床转化应用研究
四、各类病原体早期诊断试剂盒研发
五、产前筛查与产前诊断新技术与试剂盒研究
六、重大遗传病诊断与治疗研究
现任：
一、海南省抗癌协会肿瘤标志与分子医学专业委员会主任委员
二、海南省遗传学会第六届理事会常务理事兼秘书长
三、海南省医学会检验专业委员会青年委员会常务副主任委员
五、海南省司法鉴定协会法医物证专业委员会副主任委员
六、海南省医学会医学遗传学分常务委员
七、海南省临床检验专业医疗质量控制中心专家委员会委员（2023.06-2024.12）
八、中国非公立医疗机构协会检验医学分会第一届委员会首席专家兼常务委员
九、海南省抗癌协会第一届神经内分泌肿瘤专业委员会常务委员
十、海南省免疫学会第三届理事会青年工作委员会副主任委员
曾任：
一、中华医学会检验分会青年委员会委员
二、海南省医学会检验专业委员会青年委员会常务副主任委员
一、Xinping Chen, Weihua Xu, Shengmiao Fu*. Association between metoprolol and prognosis of COVID-19 patients. Journal of the American College of Cardiology，2022,1(79):e7. (SCI IF:24.094)
二、Xinping Chen; Weihua Xu; Zhichao Ma; Juan Zhu; Junjie Hu; Xiaojuan Li; Shengmiao Fu ; TTN -AS1 accelerates the growth and migration of nasopharyngeal carcinoma cells via targeting miR-876 -5p/NETO2, Molecular Therapy Oncolytics, 2021, 24: 535-546. (SCI IF:7.2)
三、Xinping Chen, Weihua Xu, Zhichao Ma, Juan Zhu, Junjie Hu, Xiaojuan Li, and Shengmiao Fu. Circ_0000215 Exerts Oncogenic Function in Nasopharyngeal Carcinoma by Targeting miR-512-5p . Frontiers in Cell and Developmental Biology, 2021, 9: 1-14. (SCI IF:6.684)
四、Xinping Chen, HeQiu Ruan, Zhichao Ma, Junjie Hu, Weihua Xu, Liyan Yin, and Shengmiao Fu*. Polymerase Chain Reaction in the Detection of miR-455-5p and Sphingosine-1 Phosphate. Journal of Biomedical Nanotechnology, 2021, 17(8): 1535-1544. (SCI IF:4.099)
五、 Xinping Chen, Tao Wu, Lingguo Li, Yu Lin, Zhichao Ma, Jinjin Xu, Hui Li, Ruoyan Chen, Kun Sun, Yuxue Luo, Chen Zhang, Fang Chen, Jiao Wang, Tingyu Kuo, Xiaojuan Li, Chunyu Geng, Feng Lin, Chaojie Huang, Junjie Hu, Jianhua Yin, Ming Liu, Ye Tao, Jiye Zhang, Rijing Ou, Huanming Yang, Jian Wang, Xun Xu, Shengmiao Fu*, Hongyan Jiang*, Xin Jin* and Haiqiang Zhang*. TSS Coverage Analysis in Plasma Cell-free DNA Reveals Disease Severity and Tissue Specificity of COVID-19 Patients. Frontiers in Genetics, 2021, 12: 1-11. (SCI IF:4.599)
六、Xinping Chen, Zhangli Lin, Junjie Hu, Shiping Chen, Shu Wen, Aizhu Wu, HongWu, Jiali Huang, Hanqiang Wang, Jun Sun, Zhiyu Peng, Yan Sun* & Shengmiao Fu*. Report of Two Novel Thalassemia Variants, HBB:c.181delG and HBA1: c.121_126delAA GACC, in Chinese Individuals. Hemoglobin, 2021, 45(1):52-55. (SCI IF:0.53)
七、Xinping Chen, Zhichao Ma, Juan Zhu, Weihua Xu, Junjie Hu, Liyan Yin* and Shengmiao Fu*. Study on the antitumor activity and mechanism of novel targeted nanodrugs based on miRNA in cervical cancer. Materials Express, 2020,10 (8):1218-1223. (SCI IF:1.65)
八、XinPing Chen, JunJie Hu, Juan Zhu, WeiHua Xu, HongXia Yao, AiZhu Wu, MeiFang Xiao, Zhe Lu, LiYan Yin*, ShengMiao Fu*. Severe Hemolytic Anemia due to combined α thalassemia and de novo Hemoglobin Sabine. Annals of Hematology, 2019, 98(3): 783-785. (SCI IF: 2.85)
九、Xin-Ping Chen, Hai-Feng Wen, Fan Zhang, Wei-Hua Xu, Zhi-Chao Ma, Sheng-Miao Fu*. Assessment of the Link between XRCC1 Arg399Gln Polymorphism and Breast Cancer: a Meta-Analysis in a Single Ethnic Group. Clin. Lab, 2017;63:725-731. (SCI IF:1.1)
十、Xingping Chen, Weihua Xu, Dafeng Xu, Shengmiao Fu*, Zhichao Ma. G12V KRAs mutations in cervical cancer under virtual microscope of molecular dynamic simulations. European journal of gynaecological oncology. 2016,1:69-74 .(SCI IF:0.9)
十一、Xin-Ping Chen, Da-Feng Xu, Wei-Hua Xu, Zhi-Chao Ma, Jia Yao, Sheng-Miao Fu*. Association studies of CYP1A1 exon7 polymorphism and -GSTM1 interaction with esophageal cancer risk: a meta-analysis in the Chinese population. Clin. Lab, 2016, 62: 1795-1802. (SCI IF:1.1)
十二、Chen XP, Xu DF, Xu WH, Yao J, Fu SM*. Glutathione-S-transferases M1/T1 gene polymorphisms and endometriosis: a meta-analysis in Chinese populations. Gynecol Endocrinol, 2015, 31(11): 840–845. (SCI IF:1.33)
十三、Xin-Ping Chen, Wei-Hua Xu, Da-Feng Xu, Xian-He Xie, Jia Yao, Sheng-Miao Fu*. GSTM1 polymorphism and lung cancer risk in the Chinese population: A meta-analysis based on 47 studies. APJCP, 2014,15(18), 7741-7746. (SCI IF:1.5)
十四、Hongxia Yao*, Xingping Chen, Lie Lin, Congming Wu, Xiangjun Fu, Hua Wang, Zhiming Yao. The spectrum of α- and β-thalassemia mutations of the Li people in Hainan Province of China. Blood Cells. Molecules and Diseases, 2014, 53, 16-20. （共同第一作者）(SCI IF:2.39)